Influence of Diabetes Mellitus on Outcomes in Patients After Left Ventricular Assist Device Implantation

被引:18
|
作者
Usoh, Chinenye O.
Sherazi, Saadia
Szepietowska, Barbara
Kutyifa, Valentina
McNitt, Scott
Papernov, Anna
Wang, Meng
Alexis, Jeffrey D.
机构
[1] Wake Forest Univ, Sch Med, Div Endocrinol & Metab, Winston Salem, NC 27109 USA
[2] Univ Rochester, Med Ctr, Heart Res Follow Up Program, Cardiol Div, Rochester, NY 14642 USA
[3] Univ Rochester, Sch Med & Dent, Div Cardiol, Rochester, NY USA
来源
ANNALS OF THORACIC SURGERY | 2018年 / 106卷 / 02期
关键词
ADVANCED HEART-FAILURE; RISK-FACTORS; STROKE; IMPACT; IMPROVEMENT; PREVALENCE; PLACEMENT;
D O I
10.1016/j.athoracsur.2018.02.045
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background. Despite previous studies, the mortality risk of patients with diabetes mellitus after left ventricular assist device (LVAD) implant remains unclear. In addition, the relationship between the degree of glycemic control and long-term mortality risk in LVAD patients with diabetes has not been established. Methods. Ninety-five nondiabetic patients and 96 diabetic patients from the University of Rochester Medical Center who received a HeartMate II (Thoratec, Pleasanton, CA) continuous-flow LVAD between May 2008 and June 2014 were included in this study. The primary outcome was all-cause mortality. Secondary outcomes included rates of infection, neurologic dysfunction, renal dysfunction, and rehospitalization. Kaplan-Meier survival analyses and Cox models were utilized. Results. During follow-up, 32 diabetic patients (33%) and 15 nondiabetic patients (16%) died after LVAD implantation. Cumulative probability of death was higher for diabetic patients when compared with nondiabetic patients (42% versus 21% at 3 years, p = 0.013). There were no significant differences in overall rates of infection, neurologic dysfunction, and rehospitalization between the two groups. However, after an initial secondary outcome event, diabetic patients continued to have a higher mortality rate when compared with nondiabetic patients. There was no statistically significant difference in the risk of death between diabetic patients with pre-LVAD hemoglobin A1c less than 7.0% and diabetic patients with pre-LVAD hemoglobin A1c 7.0% or greater (hazard ratio 1.71, 95% confidence interval: 0.72 to 4.08, p = 0.223). Conclusions. Diabetic patients who underwent LVAD implantation had a higher risk of death compared with nondiabetic patients. Adverse event rates did not differ between the two groups. Finally, the degree of glycemic control in diabetic patients before LVAD was not found to influence mortality. (C) 2018 by The Society of Thoracic Surgeons
引用
收藏
页码:555 / 560
页数:6
相关论文
共 50 条
  • [31] Caregiver status and outcomes after durable left ventricular assist device implantation
    Koeckert, Michael
    Vining, Patrick
    Reyentovich, Alex
    Katz, Stuart D.
    DeAnda, Abe, Jr.
    Philipson, Stefanie
    Balsam, Leora B.
    HEART & LUNG, 2017, 46 (02): : 74 - 78
  • [32] Aortic Insufficiency After Left Ventricular Assist Device Implantation: Predictors and Outcomes
    Kagawa, Hiroshi
    Aranda-Michel, Edgar
    Kormos, Robert L.
    Keebler, Mary
    Hickey, Gavin
    Wang, Yisi
    Mathier, Michael
    Kilic, Arman
    ANNALS OF THORACIC SURGERY, 2020, 110 (03): : 836 - 843
  • [33] Pulmonary Function Testing and Outcomes after Left Ventricular Assist Device Implantation
    Raheja, Suraj
    Nemeh, Hassan
    Williams, Celeste
    Tita, Cristina
    Selektor, Yelena
    Chamogeorgiakis, Themistokles
    Lanfear, David
    HEART SURGERY FORUM, 2019, 22 (03): : E202 - E206
  • [34] Long Term Neurocognitive Outcomes After Left Ventricular Assist Device Implantation
    Petrucci, R. J.
    Feitell, S. C.
    Gracely, E. J.
    Corvi, K. L.
    Rowe, T.
    Entwistle, J. W.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S197 - S197
  • [35] Pump Exchange after Left Ventricular Assist Device Implantation: Indications and Outcomes
    Shore, S.
    Soni, M.
    Hilbman, A.
    Patel, P.
    Mazurek, J. A.
    Justice, C.
    Fox, A.
    Tanna, M.
    Molina, M.
    Wald, J.
    Atluri, P.
    Bermudez, C.
    Goldberg, L. R.
    Rame, J.
    Birati, E. Y.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S366 - S367
  • [36] Associations Between Obesity and Outcomes After Left Ventricular Assist Device Implantation
    Chia, R.
    Kazemian, P.
    Chec, L.
    Bhikadiya, B.
    Sobieraj, M.
    Balatsky, A.
    Moshiyakhov, M.
    Burns, P.
    Barn, K.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2023, 42 (04): : S349 - S349
  • [37] Impact of Bleeding Revision on Outcomes After Left Ventricular Assist Device Implantation
    Angleitner, Philipp
    Simon, Paul
    Kaider, Alexandra
    Wiedemann, Dominik
    Dimitrov, Kamen
    Schloeglhofer, Thomas
    Rajek, Maria Angela
    Riebandt, Julia
    Laufer, Guenther
    Zimpfer, Daniel
    ANNALS OF THORACIC SURGERY, 2019, 108 (02): : 517 - 523
  • [38] Left ventricular assist device implantation in patients with left ventricular thrombus
    Dogan, Gunes
    Mariani, Silvia
    Hanke, Jasmin S.
    Deniz, Ezin
    Merzah, Ali
    Li, Tong
    Haverich, Axel
    Schmitto, Jan D.
    ARTIFICIAL ORGANS, 2021, 45 (09) : 1006 - 1013
  • [39] Driving After Left Ventricular Assist Device Implantation
    Hanke, Jasmin S.
    Riebandt, Julia
    Wahabzada, Miena
    Nur, Fatma
    Wahabzada, Angela
    Dogan, Guenes
    Feldmann, Christina
    Haverich, Axel
    Popov, Aron-Friedrich
    Zimpfer, Daniel
    Schmitto, Jan D.
    ARTIFICIAL ORGANS, 2018, 42 (07) : 695 - 699
  • [40] Flying after left ventricular assist device implantation
    Hanke, Jasmin S.
    Schmack, Bastian
    Merzah, Ali Saad
    Bounader, Karl
    Chatterjee, Anamika
    Mariani, Silvia
    Li, Tong
    Klautzsch, Erik
    Mueller, Florian
    Homann, Katharina
    Schoede, Alexandra
    Haverich, Axel
    Ruhparwar, Arjang
    Schmitto, Jan D.
    Dogan, Guenes
    ARTIFICIAL ORGANS, 2021, 45 (03) : 230 - 235